BACKGROUND AND OBJECTIVES: Acute kidney injury (AKI) requiring dialysis is associated with high mortality. Most prognostic tools used to describe case complexity and to project patient outcome lack predictive accuracy when applied in patients with AKI. In this study, we developed an AKI-specific predictive model for 60-day mortality and compared the model to the performance of two generic (Sequential Organ Failure Assessment [SOFA] and Acute Physiology and Chronic Health Evaluation II [APACHE II]) scores, and a disease specific (Cleveland Clinic [CCF]) score. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data from 1122 subjects enrolled in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network study; a multicenter randomized trial of intensive versus less intensive renal support in critically ill patients with AKI conducted between November 2003 and July 2007 at 27 VA- and university-affiliated centers. RESULTS: The 60-day mortality was 53%. Twenty-one independent predictors of 60-day mortality were identified. The logistic regression model exhibited good discrimination, with an area under the receiver operating characteristic (ROC) curve of 0.85 (0.83 to 0.88), and a derived integer risk score yielded a value of 0.80 (0.77 to 0.83). Existing scoring systems, including APACHE II, SOFA, and CCF, when applied to our cohort, showed relatively poor discrimination, reflected by areas under the ROC curve of 0.68 (0.64 to 0.71), 0.69 (0.66 to 0.73), and 0.65 (0.62 to 0.69), respectively. CONCLUSIONS: Our new risk model outperformed existing generic and disease-specific scoring systems in predicting 60-day mortality in critically ill patients with AKI. The current model requires external validation before it can be applied to other patient populations.
RCT Entities:
BACKGROUND AND OBJECTIVES:Acute kidney injury (AKI) requiring dialysis is associated with high mortality. Most prognostic tools used to describe case complexity and to project patient outcome lack predictive accuracy when applied in patients with AKI. In this study, we developed an AKI-specific predictive model for 60-day mortality and compared the model to the performance of two generic (Sequential Organ Failure Assessment [SOFA] and Acute Physiology and Chronic Health Evaluation II [APACHE II]) scores, and a disease specific (Cleveland Clinic [CCF]) score. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data from 1122 subjects enrolled in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network study; a multicenter randomized trial of intensive versus less intensive renal support in critically illpatients with AKI conducted between November 2003 and July 2007 at 27 VA- and university-affiliated centers. RESULTS: The 60-day mortality was 53%. Twenty-one independent predictors of 60-day mortality were identified. The logistic regression model exhibited good discrimination, with an area under the receiver operating characteristic (ROC) curve of 0.85 (0.83 to 0.88), and a derived integer risk score yielded a value of 0.80 (0.77 to 0.83). Existing scoring systems, including APACHE II, SOFA, and CCF, when applied to our cohort, showed relatively poor discrimination, reflected by areas under the ROC curve of 0.68 (0.64 to 0.71), 0.69 (0.66 to 0.73), and 0.65 (0.62 to 0.69), respectively. CONCLUSIONS: Our new risk model outperformed existing generic and disease-specific scoring systems in predicting 60-day mortality in critically illpatients with AKI. The current model requires external validation before it can be applied to other patient populations.
Authors: Kirsten L Johansen; Mark W Smith; Mark L Unruh; Andrew M Siroka; Theresa Z O'Connor; Paul M Palevsky Journal: Clin J Am Soc Nephrol Date: 2010-05-27 Impact factor: 8.237
Authors: J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs Journal: Intensive Care Med Date: 1996-07 Impact factor: 17.440
Authors: F Liaño; A Gallego; J Pascual; F García-Martín; J L Teruel; R Marcén; L Orofino; L Orte; M Rivera; N Gallego Journal: Nephron Date: 1993 Impact factor: 2.847
Authors: J R Le Gall; P Loirat; A Alperovitch; P Glaser; C Granthil; D Mathieu; P Mercier; R Thomas; D Villers Journal: Crit Care Med Date: 1984-11 Impact factor: 7.598
Authors: Francis Pike; Raghavan Murugan; Christopher Keener; Paul M Palevsky; Anitha Vijayan; Mark Unruh; Kevin Finkel; Xiaoyan Wen; John A Kellum Journal: Clin J Am Soc Nephrol Date: 2015-06-05 Impact factor: 8.237
Authors: Raghavan Murugan; Xiaoyan Wen; Nilesh Shah; Minjae Lee; Lan Kong; Francis Pike; Christopher Keener; Mark Unruh; Kevin Finkel; Anitha Vijayan; Paul M Palevsky; Emil Paganini; Melinda Carter; Michele Elder; John A Kellum Journal: Nephrol Dial Transplant Date: 2014-03-11 Impact factor: 5.992
Authors: Raghavan Murugan; Xiaoyan Wen; Christopher Keener; Francis Pike; Paul M Palevsky; Mark Unruh; Kevin Finkel; Anitha Vijayan; Michele Elder; Yi-Fan Chen; John A Kellum Journal: Clin J Am Soc Nephrol Date: 2015-04-10 Impact factor: 8.237
Authors: Kelly V Liang; Florentina E Sileanu; Gilles Clermont; Raghavan Murugan; Francis Pike; Paul M Palevsky; John A Kellum Journal: Clin J Am Soc Nephrol Date: 2015-12-17 Impact factor: 8.237
Authors: Kelly Chong; Samuel A Silver; Jin Long; Yuanchao Zheng; V Shane Pankratz; Mark L Unruh; Glenn M Chertow Journal: Clin J Am Soc Nephrol Date: 2017-10-17 Impact factor: 8.237
Authors: Jonathan A Bolanos; Christina M Yuan; Dustin J Little; David K Oliver; Steven R Howard; Kevin C Abbott; Stephen W Olson Journal: Clin J Am Soc Nephrol Date: 2015-09-03 Impact factor: 8.237